Search
calcium phosphate stone
75-85% of all renal stones contain calcium.
Etiology:
1) hypercalciuria
- renal tubular acidosis (RTA) type 1 (calcium phosphate)
- topiramate
2) reduced inhibitor excretion
a) Mg+2
b) pyrophosphates
c) citrate (RTA-1)4) primary hyperparathyroidism
3) primary hyperparathyroidism
4) sarcoidosis
Epidemiology:
- most common in 3rd to 5th decade of life
Pathology:
1) 1,25-dihydroxyvitamin D3 levels may be increased
2) inappropriate calciuria may occur with calcium-restricted diets
3) calcium phosphate stones form in alkaline urine
4) urinary citrate diminishes with increased urinary pH
- carbonic anhydrase inhibitors (topiramate) increase bicarbonate excreted into the urine & thus urinary pH
Laboratory:
1) serum PTH
2) renal function tests
3) urinalysis & culture
- urine microscopy
- calcium phosphate crystals in urine
4) 24 hour urine:
a) hypercalciuria: > 300 mg (men) or 250 mg (women) or > 4 mg/kg in 24 hours
b) creatinine
c) uric acid
5) 24 hour urine volume
6) serum Ca+2 is generally normal
7) stone analysis
Management:
1) correcting dietary stresses
a) Na+ increases urinary Ca+2
-> diet of < 3 g of salt/day [4]
b) animal protein increases urinary Ca+2
-> diet of < 8 oz of meat/day [4]
2) increasing urine volume > 2.5L/day
3) thiazide diuretics for hypercalciuria
a) Na+ must be restricted for urine Ca+2 to decrease by 50%
b) development of hypercalcemia suggests latent hyperparathyroidism
c) amiloride may also be of benefit
4) patients with primary hyperparathyroidism & urolithiasis
- removal of parathyroid adenoma
5) replacement of inhibitor substances
a) potassium citrate
b) pyrophosphate
c) magnesium oxide
Related
calcium phosphate crystals in urine
General
calcium stone
References
- Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed)
Lippincott-Raven, Philadelphia, 1998, pg 615
- Medical Knowledge Self Assessment Program (MKSAP) 11, 16, 17.
American College of Physicians, Philadelphia 1998, 2012, 2015
- Journal Watch 22(3):20, 2002
Borghi et al, N Engl J Med 346:77, 2002
- Prescriber's Letter 9(3):18 2002
- NEJM Knowledge+ Nephrology/Urology